FDA Classification and other enhancements in ChatFDA / ChatMDR 3.3 The latest release of our regulatory AI suite brings some interesting enhancements. A whole new feature aimed at devices under the 510(k) substantial equivalence schemes and functionality enhancement for all tools, whether you’re looking at Europe or the US and at medical devices or in-vitro …
Account creation and subscription Here’s a quick video that shows how to create a ChatMDR account from scratch, upgrade your subscription to ChatMDR Plus and also cancel your subscription without any further cost. Also, it highlights the entry of a discount code, such as those given out to select customers. Interested in a free trial …
Prompting guide Getting better answers from AI Have you ever tried using ChatMDR or ChatFDA, only to wonder if you were missing something? One key to getting the best outcome is a method known as “prompting.” This approach shapes how we communicate our requests to these powerful systems. Prompting is telling the AI model what …
ChatFDA is ChatMDR for the FDA medical device regulation in the United States. It is an AI chatbot intended to help you with 510(k) and PMA processes with the FDA. It was released in December 2024.
ChatMDR 3.1 was launched in October 2024, featuring the new GPT o1 model. This revision emphasizes advanced reasoning skills and problem-solving capabilities. Three models are supported: Fast, Smart, and Reasoning. The Reasoning model excels in analyzing complex problems step-by-step, utilizing innovative strategies like chain-of-thought reasoning to enhance accuracy.
The ChatMDR and ChatIVDR models offer Fast and Smart options for free users, while Plus and Unlimited users can access the Reasoning option. A performance comparison was conducted on MDR-related queries.
ChatMDR 3 released and introducing ChatIVDR for the IVDR regulation
